Physician profile
Dennis B Chugh
NPI 1184695058
$12,588.60
in general payments reported to CMS, 2019-2025
43 companies · $2,528 in 2025
The $2,528 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,123 · 2020: $841 · 2021: $1,059 · 2022: $2,078 · 2023: $2,494 · 2024: $2,466 · 2025: $2,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,262 · Education: $213 · Travel and Lodging: $12.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,262.22 |
| Education | $212.81 |
| Travel and Lodging | $12.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,905.62 | 2021-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Claria Mri Quad Crt-D Surescan |
| Medtronic Vascular, INC. | $807.32 | 2019-2020 | |
| Novo Nordisk INC | $638.55 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $585.74 | 2019-2025 | Watchman Flx, Watchman, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $543.93 | 2019-2025 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $533.94 | 2022-2025 | Onpattro |
| Pfizer INC. | $492.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $459.49 | 2019-2025 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $457.36 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $428.84 | 2022-2025 | Assure Wcd |
| Biotronik INC. | $414.29 | 2019-2025 | Acticor 7 Vr-T Dx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $396.68 | 2019-2025 | Jardiance |
| Amgen INC. | $381.68 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $381.11 | 2019-2023 | Xarelto |
| Esperion Therapeutics, INC. | $375.09 | 2021-2025 | Nexletol |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $344.95 | 2022-2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $339.97 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $288.00 | 2019-2025 | Jot Dx, Mitraclip, Amplatzer Amulet |
| Merck Sharp & Dohme LLC | $275.29 | 2021-2025 | Verquvo, Capvaxive |
| Sanofi-Aventis U.S. LLC | $261.42 | 2019-2024 | |
| Astellas Pharma US INC | $233.28 | 2019-2023 | Lexiscan |
| Bridgebio Pharma, INC. | $224.02 | 2025 | Attruby |
| Amarin Pharma, INC. | $218.81 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $215.86 | 2021-2025 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $170.90 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.20 | 2021-2025 | Lifevest |
| Abiomed | $151.67 | 2024-2025 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $148.64 | 2022-2023 | Arcalyst |
| Baxter Healthcare | $114.34 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Impulse Dynamics (USA) INC. | $105.46 | 2023-2024 | Optimizer, Optimizer |
| Lexicon Pharmaceuticals, INC. | $98.17 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $97.07 | 2024-2025 | |
| Recor Medical INC | $68.96 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Irhythm Technologies, INC. | $60.57 | 2022-2023 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $40.31 | 2025 | |
| Corcept Therapeutics | $30.47 | 2025 | Korlym |
| Inspire Medical Systems, INC. | $23.81 | 2024 | Inspire |
| Tactile Systems Technology INC | $23.68 | 2023 | Flexitouch Plus, Entre Plus |
| Daiichi Sankyo INC. | $23.23 | 2019 | |
| Heartflow, INC. | $22.28 | 2024 | |
| Lundbeck LLC | $14.81 | 2019 | |
| Gilead Sciences, INC. | $14.78 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Chugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.